NEWS ROOM

See the latest news from our company below or use the search feature. For more information, contact our head office or the Marketing Communications Manager directly at marcom@arazygroup.com.


 

HAVE YOUR SAY ON CLASS II DEVICE PREMARKET NOTIFICATION EXEMPTION PROPOSAL

by Arazy Group | Mar 17, 2017
The US Food and Drug Administration (FDA) is requesting public comments on a list of 1,003 class II devices that it is proposing to exempt or partially exempt from the premarket notification [510(k)] requirements.

The FDA has said it believes that the devices, which are published in the Federal Register, are sufficiently well understood and do not present risks that require premarket notification review to provide a reasonable assurance of their safety and effectiveness. 

Medical devices that are exempt from 510(k) requirements are not exempt from other regulatory controls. MedTech firms must ensure that all medical devices are manufactured under current good manufacturing practice requirements, suitable for the intended use, adequately packaged and properly labelled. All devices must also have establishment registration and device listing forms on file with the FDA.

Comments on the proposed list should be submitted no later than May 15, 2017.  Instructions on doing so can be found in the Federal Register Notice. The FDA will review comments and then consider whether the list of devices should be modified prior to publication of its final determination in the Federal Register.

Contact us today to discuss the FDA’s proposal and to discover how regulatory intelligence and registration management system LICENSALE.COM® assists MedTech firms in gaining access to 100+ markets faster and more cost-effectively than ever before.

 

 

Back to Press Room

latest news
  • Mar 21 2017
    MEET MDSAP TRANSITION DEADLINE TO CONTINUE TRADING ON CANADIAN MARKET

    In vitro diagnostic (IVD) and medical device manufacturers must transition to the Medical Device Single Audit Program (MDSAP) before January 1, 2019 in order to continue trading on the Canadian market. ...

    Read More
  • Mar 17 2017
    HAVE YOUR SAY ON CLASS II DEVICE PREMARKET NOTIFICATION EXEMPTION PROPOSAL

    The US Food and Drug Administration (FDA) is requesting public comments on a list of 1,003 class II devices that it is proposing to exempt or partially exempt from the premarket notification [510(k)] requirements. ...

    Read More
  • Mar 16 2017
    EMPOWERING REGULATORY AFFAIRS CONSULTANTS IN 100+ MARKETS

    Independent regulatory consultants are invited to register for exclusive offers that would enable them to instantly boost their MedTech product registration capabilities in 100+ markets worldwide and maximize their profit....

    Read More
  • Mar 13 2017
    REMINDER: SOUTH AFRICA’S MEDICINES CONTROL COUNCIL SETS LICENSING DEADLINES

    South Africa’s manufacturers, distributors and wholesalers of in vitro diagnostic (IVD) and medical devices must submit a license application to the Medical Control Council by the deadlines it announced in February 2017. ...

    Read More
  • Mar 7 2017
    REGULATORY UPDATE: LUMINEX

    BRAZIL: Luminex's MAGPIX® HW + SW + Reag & Calib was approved for sale with LICENSALE.COM®. ...

    Read More

VANCOUVER OFFICE

  • Phone +1 604.681.6888
  • Fax +1 604.681.6822
  • info@arazygroup.com
  •  
  • #350-1333 Johnston Street
  • Pier 32, Granville Island
  • Vancouver, British Columbia
  • Canada V6H 3R9

BACK TO TOP